Литература

1. Likoff W., Segal B.L., Kasparian H. Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease. N. Engl. J. Med. 1967; 276 (19): 1063–1066. DOI: 10.1056NEJM196705112761904
2. Kemp H., Vokonas P., Cohn P., Gorlin R. The anginal syndrome associated with normal coronary arteriograms. Report of a six year experience. Am. J. Med. 1973; 54 (6): 735–742. DOI: 10.1016/0002-9343(73)90060-0
3. Montalescot G., Sechtem U., Achenbach S., Andreotti F., Arden C., Budaj A. et al. 2013 ESC guidelines on the management of stable coronary artery disease. Eur. Heart J. 34 (38): 2949–3003. DOI: 10.1093/eurheartj/eht296
4. Knuuti J., Wijns W., Saraste A., Capodanno D., Barbato E., Funck-Brentano C. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 2019; 41 (3): 407–477. DOI: 10.1093/eurheartj/ehz425
5. Canu M., Khouri C., Marliere S., Vautrin E., Piliero N., Ormezzano O. et al. Prognostic significance of severe coronary microvascular dysfunction post-PCI in patients with STEMI: A systematic review and meta-analysis. PLoS One. 2022; 17 (5): e0268330. DOI: 10.1371/journal.pone.0268330
6. Feenstra R., Boerhou C., Woudstra J., Vink C., Wittekoek M., de Waard G. Presence of coronary endothelial dysfunction, coronary vasospasm, and adenosine-mediated vasodilatory disorders in patients with ischemia and nonobstructive coronary arteries. Circ. Cardiovasc. Interv. 2022; 15 (8): e012017. DOI: 10.1161/CIRCINTERVENTIONS.122.012017
7. Gdowski M., Murthy V., Doering M., Monroy-Gonzalez A., Slart R., Brown D.L. Association of isolated coronary microvascular dysfunction with mortality and major adverse cardiac events: a systematic review and meta-analysis of aggregate data. J. Am. Heart Assoc. 2020; 9 (9): e014954. DOI: 10.1161/JAHA.119.014954
8. Tomanek R. Structure–Function of the Coronary Hierarchy. Coronary Vasculature (Springer US). 2013; 59–81. DOI: 10.1007/978-1-4614-4887-7_4
9. Chen W., Ni M., Huang H., Cong H., Fu X., Gao W. et al. Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases (2023 Edition). Med. Comm. 2023; 4 (6): e438. DOI: 10.1002/mco2.438
10. Булаева Н.И., Голухова Е.З. Эндотелиальная дисфункция и оксидативный стресс: роль в развитии кардиоваскулярной патологии. Креативная кардиология. 2013; 7 (1): 14–22.
11. Camici P., Tschöpe C., Di Carli M., Rimoldi O., Van Linthout S. Coronary microvascular dysfunction in hypertrophy and heart failure. Cardiovasc. Res. 2020; 116 (4): 806–816. DOI: 10.1093/cvr/cvaa023
12. Guo Z., Yang Z., Song Z., Li Z., Xiao Y., Zhang Y. et al. Inflammation and coronary microvascular disease: relationship, mechanism and treatment. Front. Cardiovasc. Med. 2024; 11: 1280734. DOI: 10.3389/fcvm.2024.1280734
13. Godo S., Suda A., Takahashi J., Yasuda S., Shimokawa H. Coronary microvascular dysfunction. Arterioscler. Thromb. Vasc. Biol. 2021; 41(5): 1625–1637. DOI: 10.1161/ATVBAHA.121.316025
14. Vancheri F., Longo G., Vancheri S., Henein M. Coronary microvascular dysfunction. J. Clin. Med. 2020; 9 (9): 2880. DOI: 10.3390/jcm9092880
15. Reinstadler S., Stiermaier T., Fuernau G., de Waha S., Desch S., Metzler B. et al. The challenges and impact of microvascular injury in ST- elevation myocardial infarction. Expert Rev. Cardiovasc. Ther. 2016; 14 (4): 431–443. DOI: 10.1586/14779072.2016.1135055
16. Петросян К.B., Абросимов А.В., Гончарова Е.С. Физиологическая оценка показателей коронарного кровотока в современной стратегии интервенционного лечения ишемической болезни сердца. Грудная и сердечно-сосудистая хирургия. 2024; 66 (3): 270–281. DOI: 10.24022/0236-2791-2024-66-3-270-281
17. Голухова Е.З., Петросян К.В., Абросимов А.В., Булаева Н.И., Гончарова Е.С., Бердибеков Б.Ш. Влияние оценки фракционного и моментального резерва кровотока на клинические исходы чрескожного коронарного вмешательства: систематический обзор, метаанализ и анализ методом метарегрессии. Российский кардиологический журнал. 2023; 28 (1S): 5325. DOI: 10.15829/1560-4071-2023-5325
18. Aldiwani H., Mahdai S., Alhatemi G., Bairey Merz C. Microvascular angina: diagnosis and management. Eur/ Cardiol. 2021; 16: e46. DOI: 10.15420/ecr.2021.15
19. Vrints C., Andreotti F., Koskinas K., Rossello X., Adamo M., Ainslie J. et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur. Heart J. 2024; 45 (36): 3415–3537. DOI: 10.1093/eurheartj/ehae177
20. Ong P., Camici P., Beltrame J., Crea F., Shimokawa H., Sechtem U. et al. International standardization of diagnostic criteria for microvascular angina. Int. J. Cardiol. 2018; 250: 16–20. DOI: 10.1016/j.ijcard.2017.08.068
21. Schroder J., Michelsen M., Mygind N., Suhrs H., Bove K, Bechsgaard D. et al. Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study. Eur. Heart J. 2021; 42 (3): 228–239. DOI: 10.1093/eurheartj/ehaa944
22. Celermajer D., Sorensen K., Gooch V., Spiegelhalter D., Miller O., Sullivan I. et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340 (8828): 1111–1115. DOI: 10.1016/0140-6736(92)93147-f
23. Голухова Е.З., Асланиди И.П., Шурупова И.В., Шахова А.А., Румянцева М.Г., Трифонова Т.А., Суркова Н.А. Регионарные показатели перфузии и кровотока миокарда по данным количественной позитронно-эмиссионной томографии как индикаторы многососудистого поражения коронарного русла у больных ишемической болезнью сердца. Грудная и сердечно-сосудистая хирургия. 2023; 65 (2): 161–172. DOI: 10.24022/0236-2791-2023-65-2-161-172
24. Голухова Е.З., Шурупова И.В., Дорофеев А.В., Рычина И.Е., Трифонова Т.А., Болдырева К.М. Характеристика глобального миокардиального кровотока и коронарного резерва по данным динамической стресс-компьютерной томографии у пациентов с ишемической болезнью сердца. Грудная и сердечно-сосудистая хирургия. 2024; 66 (5): 655–665. DOI: 10.24022/0236-2791-2024-66-5-655-667
25. Murthy V., Naya M., Taqueti V., Foster C., Gaber M., Haine J. et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014; 129 (24): 2518–2527. DOI: 10.1161/CIRCULATIONAHA.113.008507
26. Zhou W., Lee J., Leung S., Lai A., Lee T., Chiang J. et al. Long-term prognosis of patients with coronary microvascular disease using stress perfusion cardiac magnetic resonance. JACC Cardiovasc. Imaging. 2021; 14 (3): 602–611. DOI: 10.1016/j.jcmg.2020.09.034
27. Thomson L., Wei J., Agarwal M., Haft-Baradaran A., Shufelt C., Mehta P.K. et al. Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction: A national heart, lung, and blood institute-sponsored study from the women’s ischemia syndrome evaluation. Circ. Cardiovasc. Imaging. 2015; 8 (4): 10.1161/CIRCIMAGING.114.002481 e002481. DOI: 10.1161/CIRCIMAGING.114.002481
28. Suzuki S., Kaikita K., Yamamoto E., Jinnouchi H., Tsujita K. Role of acetylcholine spasm provocation test as a pathophysiological assessment in nonobstructive coronary artery disease. Cardiovasc. Interv. Ther. 2021; 36 (1): 52–53. DOI: 10.1007/s12928-020-00720-z
29. Beltrame J., Crea F., Kaski J. C., Ogawa H., Ong P., Sechtem U. et al. International standardization of diagnostic criteria for vasospastic angina. Eur. Heart J. 2017; 38 (33): 2565–2568. DOI: 10.1093/eurheartj/ehv351
30. Suda A., Takahashi J., Hao K., Kikuchi Y., Shindo T., Ikeda S. et al. Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease. J. Am. Coll. Cardiol. 2019; 74 (19): 2350–2360. DOI: 10.1016/j.jacc.2019.08.1056
31. Taqueti V. Coronary microvascular dysfunction in vasospastic angina: provocative role for the microcirculation in macrovessel disease prognosis. J. Am. Coll. Cardiol. 2019; 74 (19): 2361–2364. DOI: 10.1016/j.jacc.2019.09.042
32. Bairey Merz C., Pepine C., Shimokawa H., Berry C. Treatment of coronary microvascular dysfunction. Cardiovasc. Res. 2020; 116 (4): 856–870. DOI: 10.1093/cvr/cvaa006
33. Sütsch G., Oechslin E., Mayer I., Hess O.M. Effect of diltiazem on coronary flow reserve in patients with microvascular angina. Int. J. Cardiol. 1995; 52 (2): 135–143. DOI: 10.1016/0167-5273(95)02458-9
34. Janse T., Konst R., de Vos A., Paradies V., Teerenstra S., van den Oord S. et al. Efficacy of diltiazem to improve coronary vasomotor dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial. JACC Cardiovasc. Imaging. 2022; 15 (8): 1473–1484. DOI: 10.1016/j.jcmg.2022.03.012
35. Ling H., Fu S., Xu M., Wang B., Li B., Li Y. et al. Ranolazine for improving coronary microvascular function in patients with nonobstructive coronary artery disease: a systematic review and meta-analysis with a trial sequential analysis of randomized controlled trials. Quant Imaging Med. Surg. 2024; 14 (2): 1451–1465. DOI: 10.21037/qims-23-1029
36. Kofler T., Hess S., Moccetti F., Pepine C., Attinger A., Wolfrum M. et al. Efficacy of ranolazine for treatment of coronary microvascular dysfunction – a systematic review and meta-analysis of randomized trials. CJC Open. 2020; 3 (1): 101–108. DOI: 10.1016/j.cjco.2020.09.005
37. Leonova I., Boldueva S., Zakharova O., Gaykovayam L. Trimetazidine improves symptoms and reduces microvascular dysfunction in patients with microvascular angina. Eur. Heart J. 2017; 38 (1): ehx501.P887. DOI: 10.1093/eurheartj/ehx501.P887
38. Durante W., Behnammanesh G., Peyton K. Effects of sodium-glucose co-transporter 2 inhibitors on vascular cell function and arterial remodeling. Int. J. Mol. Sci. 2021; 22 (16): 8786. DOI: 10.3390/ijms22168786
39. Peyton K., Behnammanesh G., Durante G., Durante W. Canagliflozin inhibits human endothelial cell inflammation through the induction of heme oxygenase-1. Int. J. Mol. Sci. 2022; 23 (15): 8777. DOI: 10.3390/ijms23158777
40. Shin E., Lee J., Yoo S., Park Y., Hong Y., Kim M.H. et al. A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina. Heart. 2014; 100 (19): 1531–1536. DOI: 10.1136/heartjnl-2014-305986
41. Ohyama K., Matsumoto Y., Takanami K., Ota H., Nishimiya K., Sugisawa J. et al. Coronary adventitial and perivascular adipose tissue inflammation in patients with vasospastic angina. J. Am. Coll. Cardiol. 2018; 71 (4): 414–425. DOI: 10.1016/j.jacc.2017.11.046
42. Mohri M., Shimokawa H., Hirakawa Y., Masumoto A., Takeshita A. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J. Am. Coll. Cardiol. 2003; 41 (1): 15–19. DOI: 10.1016/s0735-1097(02)02632-3
43. Алиева А.М., Чиркова Н.Н., Пинчук Т.В., Андреева О.Н., Пивоваров В.Ю. Эндотелины и сердечно-сосудистая патология. Российский кардиологический журнал. 2014; 11: 83–87. DOI: 10.15829/1560-4071-2014-11-83-87
44. Reriani M., Raichlin E., Prasad A., Mathew V., Pumper G., Nelson R. et al. Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation. 2010; 122 (10): 958–966. DOI: 10.1161/CIRCULATIONAHA.110.967406
45. Ikonomidis I., Lekakis J., Nikolaou M., Paraskevaidis I., Andreadou I., Kaplanoglou T. et al. Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation. 2008; 117 (20): 2662–2669. DOI: 10.1161/CIRCULATIONAHA.107.731877
46. Ridker P., Everett B., Thuren T., MacFadyen J., Chang W., Ballantyne C. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 2017; 377 (12): 1119–1131. DOI: 10.1056/NEJMoa1707914
47. Deussen A., Ohanyan V., Jannasch A., Yin L., Chilian W. Mechanisms of metabolic coronary flow regulation. J. Mol. Cell. Cardiol. 2012; 52 (4): 794–801. DOI: 10.1016/j.yjmcc.2011.10.001
48. Crea F., Gaspardone A., Araujo L., Da Silva R., Kaski J. C., Davies G., Maseri A. Effects of aminophylline on cardiac function and regional myocardial perfusion: implications regarding its antiischemic action. Am. Heart J. 1994; 127 (4 Pt 1): 817–824. DOI: 10.1016/0002-8703(94)90548-7

Об авторах

• Афанасьева Маргарита Андреевна, ординатор; ORCID
• Кубова Маида Чиназовна, науч. сотр., врач-кардиолог; ORCID
• Булаева Наида Ибадулаевна, канд. биол. наук, доцент, заведующая отделом координации и сопровождения научно-исследовательской деятельности, врач-кардиолог; ORCID